MIPS researcher receives grant from MS Research Australia
Professor Jonathan Baell from the Medicinal Chemistry theme of the Monash Institute of Pharmaceutical Sciences (MIPS) has been awarded a Project Grant from MS Research Australia to develop a new test to monitor multiple sclerosis (MS) disease progression and cell activity.
As part of a major $2.9 million grants program announced by MS Research Australia and MS Australia, Professor Baell and his co-investigators are one of 20 scientific research teams across Australia to receive grants for their work into MS. The team have received a three year grant of $235,000.
Being able to correctly monitor the level of MS activity is critical during clinical drug trials, where the ability of a new drug to stop MS activity is being assessed. Currently, this poses a challenge in clinical trials and there is no one test that can accurately measure MS activity.
Professor Baell and his team are working to develop techniques to determine the level of disease activity and MS progression. This could help fill an unmet need in clinical trials for new MS drugs by helping to identify effective drugs to treat progressive MS sooner and more accurately.
Professor Baell is working with researchers from Monash University, University of Melbourne, the Florey Institute of Neuroscience and Mental Health and Australia's Nuclear Science and Technology Organisation (ANSTO). More information on the Project Grant can be found here.